A transgenic model for conditional induction and rescue of portal hypertension reveals a role of VEGF-mediated regulation of sinusoidal fenestrations

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  May, Dalit ^a,c   Djonov, Valentin ^b   Zamir, Gideon ^a   Bala, Miklosh ^a   Safadi, Rifaat ^a   Sklair Levy, Miriam ^a   Keshet, Eli ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF BERN   (Switzerland)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CELL TRANSFORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; LIVER CIRCULATION; LIVER FIBROSIS; LIVER INJURY; LIVER SINUSOID; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PORTAL HYPERTENSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; SPLENOMEGALY; STELLATE CELL; TRANSGENIC MOUSE; ANIMAL; GENETICS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER; METABOLISM; NORTHERN BLOTTING; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; VASCULARIZATION; WESTERN BLOTTING;

MUS MUSCULUS;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; HYPERTENSION, PORTAL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79960109597     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021478     Document Type: Article

References (26)

1. Friedman SL, (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172.
2. Sanyal AJ, Bosch J, Blei A, Arroyo V, (2008) Portal hypertension and its complications. Gastroenterology 134: 1715-1728.
3. Bosch J, (2007) Vascular deterioration in cirrhosis: the big picture. J Clin Gastroenterol 41 (Suppl 3): S247-253.
4. Funyu J, Mochida S, Inao M, Matsui A, Fujiwara K, (2001) VEGF can act as vascular permeability factor in the hepatic sinusoids through upregulation of porosity of endothelial cells. Biochem Biophys Res Commun 280: 481-485.
5. Yokomori H, Oda M, Yoshimura K, Nagai T, Ogi M, et al. (2003) Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells. Liver Int 23: 467-475.
6. Carpenter B, Lin Y, Stoll S, Raffai RL, McCuskey R, et al. (2005) VEGF is crucial for the hepatic vascular development required for lipoprotein uptake. Development 132: 3293-3303.
7. Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, et al. (2006) Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 290: H547-559.
8. Bosch J, Abraldes JG, Fernandez M, Garcia-Pagan JC. Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension. J Hepatol 53: 558-567.
9. Kistner A, Gossen M, Zimmermann F, Jerecic J, Ullmer C, et al. (1996) Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci U S A 93: 10933-10938.
10. May D, Gilon D, Djonov V, Itin A, Lazarus A, et al. (2008) Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation. Proc Natl Acad Sci U S A 105: 282-287.
11. Dor Y, Djonov V, Abramovitch R, Itin A, Fishman GI, et al. (2002) Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. Embo J 21: 1939-1947.
12. Djonov V, Schmid M, Tschanz SA, Burri PH, (2000) Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ Res 86: 286-292.
13. Maharaj AS, Saint-Geniez M, Maldonado AE, D'Amore PA, (2006) Vascular endothelial growth factor localization in the adult. Am J Pathol 168: 639-648.
14. Fraser R, Dobbs BR, Rogers GW, (1995) Lipoproteins and the liver sieve: the role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 21: 863-874.
15. Arimoto J, Ikura Y, Suekane T, Nakagawa M, Kitabayashi C, et al. (2009) Expression of LYVE-1 in sinusoidal endothelium is reduced in chronically inflamed human livers. J Gastroenterol.
16. Baruch Y, Neubauer K, Ritzel A, Wilfling T, Lorf T, et al. (2004) Von Willebrand gene expression in damaged human liver. Hepatogastroenterology 51: 684-688.
17. Hollestelle MJ, Geertzen HG, Straatsburg IH, van Gulik TM, van Mourik JA, (2004) Factor VIII expression in liver disease. Thromb Haemost 91: 267-275.
18. Garcia-Tsao G, Lim JK, (2009) Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 104: 1802-1829.
19. Maharaj AS, D'Amore PA, (2007) Roles for VEGF in the adult. Microvasc Res 74: 100-113.
20. Yamane A, Seetharam L, Yamaguchi S, Gotoh N, Takahashi T, et al. (1994) A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 9: 2683-2690.
21. Ulbrich G, Pinter M, Reiberger T, Ferlitsch A, Sieghart W, et al. (2010) Interim safety-analysis of the AVATACE-1 trial (Bevacizumab as inhibitor of collateral tumor-vessel growth during trasarterial chemoembolisation (TACE) for hepatocellular carcinoma- a double blind randomized placebo-controlled pilot trial). Abstract EASL 2010, Journal of Hepatology Supplement.
22. Menon KV, Shah V, Kamath PS, (2004) The Budd-Chiari syndrome. N Engl J Med 350: 578-585.
23. Cao S, Yaqoob U, Das A, Shergill U, Jagavelu K, et al. (2010) Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells. J Clin Invest 120: 2379-2394.
24. Friedman SL, Arthur MJ, (1989) Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest 84: 1780-1785.
25. Iredale JP, (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117: 539-548.
26. Wong L, Yamasaki G, Johnson RJ, Friedman SL, (1994) Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 94: 1563-1569.